Mohammed Almohammadi/LinkedIn
Apr 2, 2026, 04:28
Mohammed Almohammadi: Etiologic Spectrum and Diagnostic Challenges of Hypocellular Marrow Findings
Mohammed Almohammadi, Medical Director of Laboratory Services at Dr. Sulaiman AL Habib Medical Group, shared a post on LinkedIn:
“In Hematopathology, observing an ’empty’ marrow is a straightforward finding.
However, this observation does not tell the whole story.
The underlying etiology is not always Aplastic Anemia, which is primarily idiopathic and autoimmune in nature.
Other potential causes include:
- Inherited marrow failure, which can sometimes be diagnosed in early adulthood with misleadingly minimal syndromic features
- Secondary effects of infection or toxic exposure
- Hypocellular Myelodysplastic Syndromes (MDS)
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
Understanding these possibilities is crucial for accurate diagnosis and treatment.”
Stay updated with Hemostasis Today.
-
Oct 9, 2026, 16:23David Boone: Distinguishing Stroke Prevention from Rhythm Control in Atrial Fibrillation
-
Oct 9, 2026, 15:27Mohamed Hegazi: Geostatistical Modelling Maps Global β-Thalassaemia Carrier Prevalence
-
Oct 9, 2026, 15:15Maha Othman: Uncovering the Consensus on TXA in TBI – Call for Collaboration on a Landmark Umbrella Review
-
Oct 9, 2026, 15:07Daniel D. Han: How Inhalation Product Exposure Impairs Cardiac and Platelet Recovery After MI
-
Oct 9, 2026, 14:58William Toole: How Ultrasound-Guided PRP Therapy Relieves Joint and Tendon Pain
-
Oct 9, 2026, 14:50Shayan Mohammadmoradi: In Corpus Christi for the 20th Midwest Platelet Conference
-
Oct 9, 2026, 14:37Tariq Tramboo: High Platelet Concentrate for Osteoarthritis Knee – Recent Meta-Analyses
-
Oct 9, 2026, 14:26Yousma Khan: Hematology Series – Beyond RBCs, WBCs and Platelets
-
Oct 9, 2026, 14:13Jesus Ardila Novoa: Why the WHO’s Historic Essential Medicines List Decision Is Just the Beginning